| Published October 28, 2025

Nanoform enters strategic partnership with Revio Therapeutics

Text: Hanna Norrlid | [email protected]
Nanoform and Revio Therapeutics have entered into a collaboration to develop GLIORA, a nanoformulated hydrogel for local and long-acting treatment of high-risk glioma. Using Nanoform's patented CESS technology and a...

You need to create a user account to read this article.

With a subscription you unlock more content on BioStock.